Nobuo Sanjo

3.2k total citations
78 papers, 1.7k citations indexed

About

Nobuo Sanjo is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Nobuo Sanjo has authored 78 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 16 papers in Neurology and 16 papers in Physiology. Recurrent topics in Nobuo Sanjo's work include Prion Diseases and Protein Misfolding (24 papers), Alzheimer's disease research and treatments (15 papers) and Multiple Sclerosis Research Studies (11 papers). Nobuo Sanjo is often cited by papers focused on Prion Diseases and Protein Misfolding (24 papers), Alzheimer's disease research and treatments (15 papers) and Multiple Sclerosis Research Studies (11 papers). Nobuo Sanjo collaborates with scholars based in Japan, Canada and United States. Nobuo Sanjo's co-authors include Hidehiro Mizusawa, Peter St George‐Hyslop, Fusheng Chen, Yongjun Gu, Toshitaka Kawarai, Anurag Tandon, Hiroshi Hasegawa, Takanori Yokota, Paul Fraser and Ekaterina Rogaeva and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Nobuo Sanjo

72 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuo Sanjo Japan 18 933 611 338 327 279 78 1.7k
An Snellinx Belgium 16 1.1k 1.2× 776 1.3× 320 0.9× 212 0.6× 465 1.7× 24 2.0k
Isao Nishimura Japan 17 953 1.0× 545 0.9× 422 1.2× 270 0.8× 548 2.0× 25 1.7k
Chengyong Shen United States 24 1.1k 1.2× 391 0.6× 599 1.8× 317 1.0× 487 1.7× 41 2.0k
Satoshi Tsunoda Japan 17 1.0k 1.1× 648 1.1× 173 0.5× 169 0.5× 225 0.8× 30 2.1k
Lei Wen China 19 751 0.8× 308 0.5× 209 0.6× 245 0.7× 604 2.2× 51 1.7k
Karoly Nikolich United States 18 966 1.0× 434 0.7× 153 0.5× 196 0.6× 484 1.7× 21 1.9k
Jan Xu United States 27 1.2k 1.3× 1.1k 1.8× 186 0.6× 250 0.8× 467 1.7× 37 2.8k
Sumiko Kiryu‐Seo Japan 30 1.3k 1.3× 516 0.8× 195 0.6× 275 0.8× 898 3.2× 64 2.5k
Nathalie Brouwers Belgium 26 1.2k 1.3× 1.6k 2.5× 668 2.0× 309 0.9× 263 0.9× 46 2.6k
Jung A. Woo United States 20 612 0.7× 389 0.6× 172 0.5× 161 0.5× 255 0.9× 45 1.1k

Countries citing papers authored by Nobuo Sanjo

Since Specialization
Citations

This map shows the geographic impact of Nobuo Sanjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Sanjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Sanjo more than expected).

Fields of papers citing papers by Nobuo Sanjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Sanjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Sanjo. The network helps show where Nobuo Sanjo may publish in the future.

Co-authorship network of co-authors of Nobuo Sanjo

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Sanjo. A scholar is included among the top collaborators of Nobuo Sanjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Sanjo. Nobuo Sanjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yokoyama, Kota, et al.. (2024). Brain perfusion SPECT in dementia: what radiologists should know. Japanese Journal of Radiology. 42(11). 1215–1230. 4 indexed citations
3.
Kosami, Koki, Ryusuke Ae, Tsuyoshi Hamaguchi, et al.. (2022). Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases. Journal of Neurology Neurosurgery & Psychiatry. 93(7). 779–784. 8 indexed citations
4.
Niino, Masaaki, Tatsusada Okuno, Nobuo Sanjo, et al.. (2022). Health-related quality of life in Japanese patients with multiple sclerosis. Journal of Neurology. 270(2). 1011–1018. 1 indexed citations
6.
Sanjo, Nobuo, et al.. (2022). Entrapment partly participates in the longitudinal progression of neuropathy with anti-MAG antibodies. Revue Neurologique. 179(1-2). 118–122. 1 indexed citations
7.
Hayashi, Yuichi, Tsuyoshi Hamaguchi, Katsuya Satoh, et al.. (2022). Specific electroencephalogram features in the very early phases of sporadic Creutzfeldt–Jakob disease. Journal of the Neurological Sciences. 437. 120265–120265. 2 indexed citations
8.
Yoshii, Toshitaka, Satoru Egawa, Yu Matsukura, et al.. (2022). Case Report: Dural Dissection With Ventral Spinal Fluid-Filled Collection in Superficial Siderosis: Insights Into the Pathology From Anterior-Approached Surgical Cases. Frontiers in Neurology. 13. 919280–919280. 3 indexed citations
9.
Yokote, Hiroaki, Shuta Toru, Yoichiro Nishida, et al.. (2020). Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. Journal of Neuroimmunology. 351. 577466–577466. 6 indexed citations
10.
Sanjo, Nobuo, Yukiko Shishido‐Hara, Yoshiki Sekijima, et al.. (2018). A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy. Journal of Neurology. 266(2). 369–377. 16 indexed citations
11.
Ito, Yoko, Nobuo Sanjo, Atsushi Kobayashi, et al.. (2018). Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene. Biochemical and Biophysical Research Communications. 496(4). 1055–1061. 5 indexed citations
12.
Sanjo, Nobuo, et al.. (2017). Whole-Day Gait Monitoring in Patients with Alzheimer’s Disease: A Relationship between Attention and Gait Cycle. Journal of Alzheimer s Disease Reports. 1(1). 1–8. 14 indexed citations
13.
Sanjo, Nobuo, Makoto Tomita, Ryuichiro Atarashi, et al.. (2014). Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 4(5). e004968–e004968. 37 indexed citations
14.
Sano, Kazunori, Katsuya Satoh, Ryuichiro Atarashi, et al.. (2013). Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay. PLoS ONE. 8(1). e54915–e54915. 103 indexed citations
15.
Sanjo, Nobuo, et al.. (2013). Visual Reproduction on the Wechsler Memory Scale-Revised as a Predictor of Alzheimer’s Disease in Japanese Patients with Mild Cognitive Impairments. Dementia and Geriatric Cognitive Disorders. 35(3-4). 165–176. 11 indexed citations
17.
Jin, Haifeng, Nobuo Sanjo, Toshiki Uchihara, et al.. (2010). Presenilin-1 Holoprotein is an Interacting Partner of Sarco Endoplasmic Reticulum Calcium-ATPase and Confers Resistance to Endoplasmic Reticulum Stress. Journal of Alzheimer s Disease. 20(1). 261–273. 27 indexed citations
18.
Chen, Fusheng, Hiroshi Hasegawa, Gerold Schmitt‐Ulms, et al.. (2006). TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity. Nature. 440(7088). 1208–1212. 240 indexed citations
19.
Petit-Paitel, Agnès, Toshitaka Kawarai, Erwan Paitel, et al.. (2005). Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations. Journal of Biological Chemistry. 280(40). 34025–34032. 269 indexed citations
20.
Chen, Fusheng, Anurag Tandon, Nobuo Sanjo, et al.. (2003). Presenilin 1 and Presenilin 2 Have Differential Effects on the Stability and Maturation of Nicastrin in Mammalian Brain. Journal of Biological Chemistry. 278(22). 19974–19979. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026